La TC preoperatoria no predice la resecabilidad en la carcinomatosis peritoneal

1.    Sugarbaker P.H., Cunliffe W.J., Belliveau J., et al:  Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer.  Semin Oncol 16. (4 Suppl 6): 83-97.1989; 
2.    Koppe M.J., Boerman O.C., Oyen W.J., et al:  Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.  Ann Surg 243. 212-222.2006; 
3.    Smeenk R.M., van Velthuysen M.L., Verwaal V.J., et al:  Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.  Eur J Surg Oncol 34. 196-201.2008;
4.    Verwaal V.J., Bruin S., Boot H., et al:  8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.  Ann Surg Oncol 15. 2426-2432.2008; 
5.    Glehen O., Kwiatkowski F., Sugarbaker P.H., et al:  Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.  J Clin Oncol 22. 3284-3292.2004;
6.    Bijelic L., Yan T.D., Sugarbaker P.H.:  Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms.  J Surg Oncol 98. 295-299.2008;
7.    Elias D., Lefevre J.H., Chevalier J., et al:  Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.  J Clin Oncol 27. 681-685.2009;
8.    Elias D., Glehen O., Pocard M., et al:  A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix.  Ann Surg 251. 896-901.2010; 
9.    Harmon R.L., Sugarbaker P.H.:  Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer.  Int Semin Surg Oncol 2. 3.2005;
10.    Chua T.C., Moran B.J., Sugarbaker P.H., et al:  Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.  J Clin Oncol 30. 2449-2456.2012;
11.    Verwaal V.J., van Ruth S., de Bree E., et al:  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.  J Clin Oncol 21. 3737-3743.2003;
12.    Elias D., Blot F., El Otmany A., et al:  Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.  Cancer 92. 71-76.2001; 
13.    da Silva R.G., Sugarbaker P.H.:  Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.  J Am Coll Surgeons 203. 878-886.2006;
14.    Yan T.D., Morris D.L., Shigeki K., et al:  Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: expert consensus statement.  J Surg Oncol 98. 224-227.2008;
15.    Koh J.L., Yan T.D., Glenn D., et al:  Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis.  Ann Surg Oncol 16. 327-333.2009; 
16.    Esquivel J., Chua T.C., Stojadinovic A., et al:  Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study.  J Surg Oncol 102. 565-570.2010;
17.    Jacquet P., Jelinek J.S., Steves M.A., et al:  Evaluation of computed tomography in patients with peritoneal carcinomatosis.  Cancer 72. 1631-1636.1993; 
18.    Shen P., Hawksworth J., Lovato J., et al:  Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma.  Ann Surg Oncol 11. 178-186.2004; 
19.    Goere D., Malka D., Tzanis D., et al:  Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?.  Ann Surg 257. 1065-1071.2013; 
20.    Pelz J.O., Stojadinovic A., Nissan A., et al:  Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis.  J Surg Oncol 99. 9-15.2009